The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,673.50
Bid: 1,673.00
Ask: 1,673.50
Change: 3.50 (0.21%)
Spread: 0.50 (0.03%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets boosted by earnings, Eurozone PMIs

Wed, 24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China.easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher after results or trading updates this morning. Meanwhile, figures from blue chips Daimler, Volvo and Alstom also impressed over in Europe.In economic data, the Eurozone purchasing managers' indices (PMIs) for both the services and manufacturing sectors beat expectations in July, pushing the composite PMI from 48.7 to 50.4, well ahead of the 49.1 consensus forecast. This was the best reading of private-sector activity in 18 months."Sure, unemployment remains frighteningly high, political instability keeps the market on its toes and deep austerity will be biting hard for some time, but services and manufacturing facets of the Eurozone economy are turning a page," said Market Strategist Ishaq Siddiqi from ETX Capital.Markets were also digesting comments from Goldman Sachs analysts who said they see a near 50% probability that the Monetary Policy Committee will modify its stance at the August meeting. The most likely change would be a cut in the Bank rate or remuneration rate on bank reserves, but additional quantitative easing looks less likely. Chinese data disappointsHSBC's flash China manufacturing PMI fell from 48.2 to 47.7 in July, missing expectations of no change. "Under normal circumstances, this would weigh heavily on investor sentiment and therefore risk assets, such as the European indices, however that is not the case this morning," said Market Analyst Craig Erlam from Alpari.Downside risks to growth were tempered yesterday by the country's Premier Li Keqiang who assured that the pace of expansion would not fall below the "bottom line" of 7.0% this year, indicating that any slowdown would be met with more stimulus."This should limit the short-term negativity surrounding poor Chinese data because it seems for now that growth is guaranteed to remain at these higher levels," Erlam said.FTSE 100: Updates from heavyweights impresseasyJet surged this morning after the budget airline achieved a 10.5% rise in third-quarter revenue to £1.14bn, bolstered by an increase in capacity and growth in revenue per seat. Chip designer ARM Holdings was also on the rise after delivering better-than-expected second-quarter sales and profits. The company also said that dollar revenues would be "at least in line" with market expectations.Food ingredients firm Tate & Lyle gained after saying that adjusted profits were in line with expectations in spite of tough weather conditions in the States in the first quarter.Foodservice and support services company Compass rose after saying expectations for the full year remain "positive and unchanged" following a strong third quarter.Kingfisher, the DIY retail group behind B&Q and Screwfix, said it is on track to hit expectations for the first half after a pick-up in activity in the second quarter, causing shares to rise.Pharmaceuticals giant GlaxoSmithKline was trading higher this morning ahead of its results out this afternoon.Exchange operator London Stock Exchange was subdued after going ex-dividend. Engineering and project management group AMEC was trading lower after HSBC downgraded the stock to 'neutral' and cut its target price from 1,200p to 1,130p.FTSE 100 - RiserseasyJet (EZJ) 1,439.00p +7.71%ARM Holdings (ARM) 940.50p +4.73%Glencore Xstrata (GLEN) 292.40p +3.43%Weir Group (WEIR) 2,173.00p +2.89%Tate & Lyle (TATE) 847.00p +2.85%International Consolidated Airlines Group SA (CDI) (IAG) 293.90p +2.80%Travis Perkins (TPK) 1,720.00p +2.69%Antofagasta (ANTO) 875.50p +2.16%Melrose Industries (MRO) 273.60p +1.90%TUI Travel (TT.) 371.00p +1.87%FTSE 100 - FallersMeggitt (MGGT) 538.00p -1.65%Croda International (CRDA) 2,421.00p -1.14%British Land Co (BLND) 610.00p -1.13%BG Group (BG.) 1,198.00p -1.03%Sage Group (SGE) 356.00p -0.84%Hammerson (HMSO) 533.50p -0.56%Amec (AMEC) 1,066.00p -0.56%Hargreaves Lansdown (HL.) 1,006.00p -0.40%Barclays (BARC) 320.45p -0.40%Fresnillo (FRES) 1,088.00p -0.28%FTSE 250 - RisersImagination Technologies Group (IMG) 269.20p +7.38%Wetherspoon (J.D.) (JDW) 708.00p +5.99%National Express Group (NEX) 259.00p +5.50%Hochschild Mining (HOC) 171.60p +4.63%Mitchells & Butlers (MAB) 433.30p +4.41%Bumi (BUMI) 225.00p +3.93%Premier Farnell (PFL) 228.40p +3.12%Dialight (DIA) 1,221.00p +3.04%Playtech (PTEC) 706.50p +2.39%St. Modwen Properties (SMP) 308.80p +2.18%FTSE 250 - FallersBeazley (BEZ) 215.90p -4.34%TalkTalk Telecom Group (TALK) 246.80p -2.06%Renishaw (RSW) 1,535.00p -2.04%Kier Group (KIE) 1,395.00p -1.97%Man Group (EMG) 86.15p -1.94%Chemring Group (CHG) 301.00p -1.67%Carpetright (CPR) 666.00p -1.62%Great Portland Estates (GPOR) 577.50p -1.45%Anite (AIE) 130.00p -1.44%Barr (A.G.) (BAG) 562.00p -1.23%BC
More News
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.